NCT04448379 2020-12-28Efficacy and Safety of JMT101 Combined With Afatinib (or Osimertinib) in Patients With Non-Small Cell Lung CancerShanghai JMT-Bio Inc.Phase 1 Unknown48 enrolled
NCT02906163 2016-09-19First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care TherapySciClone PharmaceuticalsPhase 1/2 Unknown188 enrolled